Summary and Conclusions
| Rev Diabet Stud,
2009,
6(3):223-224 |
DOI 10.1900/RDS.2009.6.223 |
C-Peptide is Relevant in Type 1 Diabetes and its Complications: Summary and Conclusions to the Special Issue
John Wahren1, Anders A.F. Sima2,3
1Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
2Department of Pathology, Wayne State University, Detroit, MI, USA
3Department of Neurology, Wayne State University, Detroit, MI, USA
Address correspondence to: Anders A.F. Sima, e-mail: asima@med.wayne.edu
Manuscript submitted October 23, 2009; accepted October 27, 2009.
Abstract
n/a
Fulltext:
 HTML
,  PDF
(33KB)
This article has been cited by other articles:
|
Design of a Bioartificial Pancreas+
Opara EC, Mirmalek-Sani SH, Khanna O, Moya ML, Brey EM
J Investig Med 2010. 58(7):831-837
|
|
|
Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein
Mughal RS, Scragg JL, Lister P, Warburton P, Riches K, O’Regan DJ, Ball SG, Turner NA, Porter KE
Diabetologia 2010. 53(8):1761-1771
|
|
|
